Mark W. Lingen to Receptor, ErbB-2
This is a "connection" page, showing publications Mark W. Lingen has written about Receptor, ErbB-2.
Connection Strength
0.196
-
Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. Head Neck Pathol. 2018 Mar; 12(1):95-104.
Score: 0.135
-
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. Clin Cancer Res. 2005 Nov 15; 11(22):8105-8.
Score: 0.060